+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Neurovascular Devices Market Research Report by Disease Pathology, Devices, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 225 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5454977
UP TO OFF until Dec 31st 2022
The Global Neurovascular Devices Market size was estimated at USD 2,889.20 million in 2021, USD 3,084.80 million in 2022, and is projected to grow at a CAGR of 6.94% to reach USD 4,323.05 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Neurovascular Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Disease Pathology, the market was studied across Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, and Stenosis.
  • Based on Devices, the market was studied across Cerebral Angioplasty and Stenting Systems, Cerebral Embolization and Aneurysm Coiling devices, Neurothrombectomy Devices, and Support Devices. The Cerebral Angioplasty and Stenting Systems is further studied across Embolic Coils, Flow Diverters, and Liquid Embolic Agents. The Cerebral Embolization and Aneurysm Coiling devices is further studied across Carotid Artery Stents and Embolic Protection Systems. The Neurothrombectomy Devices is further studied across Clot Retrieval Devices, Suction Devices, and Vascular Snares. The Support Devices is further studied across Micro Catheters and Micro Guidewires.
  • Based on End-User, the market was studied across Ambulatory Surgical Centers, Hospitals, and Specialized Clinics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Neurovascular Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neurovascular Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Neurovascular Devices Market, including Abbott Laboratories, Acandis GmbH, B. BRAUN MELSUNGEN AG, Cerus Endovascular Inc., Evasc Medical Systems, Gynesonics, Inc., Integer Holdings Corporation, Integra Lifesciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Oxford Endovascular Ltd, Penumbra, Inc., phenox GmbH, Rapid Medical, Secant Group, LLC, Sensome, Stryker Corporation, and Terumo Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neurovascular Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurovascular Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurovascular Devices Market?
4. What is the competitive strategic window for opportunities in the Global Neurovascular Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Neurovascular Devices Market?
6. What is the market share of the leading vendors in the Global Neurovascular Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Neurovascular Devices Market?
Frequently Asked Questions about the Global Neurovascular Devices Market

What is the estimated value of the Global Neurovascular Devices Market?

The Global Neurovascular Devices Market was estimated to be valued at $2889.2 Million in 2021.

What is the growth rate of the Global Neurovascular Devices Market?

The growth rate of the Global Neurovascular Devices Market is 6.9%, with an estimated value of $4323.05 Million by 2027.

What is the forecasted size of the Global Neurovascular Devices Market?

The Global Neurovascular Devices Market is estimated to be worth $4323.05 Million by 2027.

Who are the key companies in the Global Neurovascular Devices Market?

Key companies in the Global Neurovascular Devices Market include Abbott Laboratories, Acandis GmbH, B. BRAUN MELSUNGEN AG, Cerus Endovascular Inc., Evasc Medical Systems, Gynesonics, Inc., Integer Holdings Corporation, Integra Lifesciences Corporation and Medtronic PLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of a brain aneurysm and neurological disorders
5.1.1.2. Rising demand for minimally invasive procedures for brain surgeries
5.1.1.3. Technological advancements related to neurovascular devices
5.1.2. Restraints
5.1.2.1. High cost associated with the neurovascular interventions and devices
5.1.3. Opportunities
5.1.3.1. Emerging research activities in the field of neurovascular therapies
5.1.3.2. Ongoing product development and approvals of neurovascular devices
5.1.4. Challenges
5.1.4.1. Limited neurosurgeons across the globe
5.2. Cumulative Impact of COVID-19
6. Neurovascular Devices Market, by Disease Pathology
6.1. Introduction
6.2. Aneurysm
6.3. Arteriovenous Malformation and Fistulas (AVM)
6.4. Ischemic Stroke
6.5. Stenosis
7. Neurovascular Devices Market, by Devices
7.1. Introduction
7.2. Cerebral Angioplasty and Stenting Systems
7.3.1. Embolic Coils
7.3.2. Flow Diverters
7.3.3. Liquid Embolic Agents
7.3. Cerebral Embolization and Aneurysm Coiling devices
7.4.1. Carotid Artery Stents
7.4.2. Embolic Protection Systems
7.4. Neurothrombectomy Devices
7.5.1. Clot Retrieval Devices
7.5.2. Suction Devices
7.5.3. Vascular Snares
7.5. Support Devices
7.6.1. Micro Catheters
7.6.2. Micro Guidewires
8. Neurovascular Devices Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialized Clinics
9. Americas Neurovascular Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Neurovascular Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Neurovascular Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Acandis GmbH
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. B. BRAUN MELSUNGEN AG
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Cerus Endovascular Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Evasc Medical Systems
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Gynesonics, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Integer Holdings Corporation
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Integra Lifesciences Corporation
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Johnson & Johnson Services, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Medtronic PLC
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Merit Medical Systems, Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. MicroPort Scientific Corporation
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Oxford Endovascular Ltd
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Penumbra, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. phenox GmbH
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Rapid Medical
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Secant Group, LLC
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Sensome
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Stryker Corporation
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Terumo Corporation
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL NEUROVASCULAR DEVICES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL NEUROVASCULAR DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL NEUROVASCULAR DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL NEUROVASCULAR DEVICES MARKET DYNAMICS
FIGURE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2021 VS 2027 (%)
FIGURE 12. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL NEUROVASCULAR DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY DISEASE PATHOLOGY, 2027
FIGURE 14. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION AND FISTULAS (AVM), 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2021 VS 2027 (%)
FIGURE 19. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL NEUROVASCULAR DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY DEVICES, 2027
FIGURE 21. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION AND ANEURYSM COILING DEVICES, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, 2018-2027 (USD MILLION)
FIGURE 30. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 36. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL NEUROVASCULAR DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 38. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2027 (USD MILLION)
FIGURE 39. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 40. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2027 (USD MILLION)
FIGURE 41. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 43. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 44. AMERICAS NEUROVASCULAR DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 45. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. CANADA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 51. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 52. UNITED STATES NEUROVASCULAR DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 53. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 55. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 56. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 57. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. CHINA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. INDIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 73. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. ITALY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. POLAND NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. QATAR NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 90. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 91. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 92. UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 93. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 94. GLOBAL NEUROVASCULAR DEVICES MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 95. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 96. GLOBAL NEUROVASCULAR DEVICES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL NEUROVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION AND FISTULAS (AVM), 2018-2027 (USD MILLION)
TABLE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION AND FISTULAS (AVM), BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION AND FISTULAS (AVM), BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION AND ANEURYSM COILING DEVICES, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION AND ANEURYSM COILING DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION AND ANEURYSM COILING DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, BY REGION, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2027 (USD MILLION)
TABLE 54. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 55. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 56. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, 2018-2027 (USD MILLION)
TABLE 57. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 58. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 59. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, 2018-2027 (USD MILLION)
TABLE 60. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, BY REGION, 2018-2027 (USD MILLION)
TABLE 61. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, BY REGION, 2018-2027 (USD MILLION)
TABLE 62. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 63. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2027 (USD MILLION)
TABLE 64. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 65. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 66. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 67. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 68. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 69. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2027 (USD MILLION)
TABLE 70. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 71. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 72. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 73. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 74. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 75. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 76. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 77. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 78. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 79. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 80. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 81. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 82. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 83. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 84. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 85. CANADA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 86. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 87. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 88. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 89. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 90. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 91. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 92. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 93. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 94. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 95. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 96. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 97. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 98. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 99. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 100. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 101. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 102. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 103. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 104. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 105. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 106. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 107. CHINA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 108. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 109. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 110. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 111. INDIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 112. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 113. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 114. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 115. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 116. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 117. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 118. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 119. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 120. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 121. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 122. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 123. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 124. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 125. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 126. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 127. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 128. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 129. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 130. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 131. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 132. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 133. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 134. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 135. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 136. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 137. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 138. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 139. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 140. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 141. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 142. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 143. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 144. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 145. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 146. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 147. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 148. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 149. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 150. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 156. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 157. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 158. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 159. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 160. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 161. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 162. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 163. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 164. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 165. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 166. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 167. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 168. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 169. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 170. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 171. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 172. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 173. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 174. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 175. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 176. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 177. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 178. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 179. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 180. ITALY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 181. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 182. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 183. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 184. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 185. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 186. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 187. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 188. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 189. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 190. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 191. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 192. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 193. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 194. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 195. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 196. POLAND NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 197. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 198. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 199. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 200. QATAR NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 201. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 202. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 203. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 204. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 205. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 206. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 207. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 208. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 209. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 210. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 211. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 212. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 213. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 214. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 215. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 216. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 217. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 218. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 219. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 220. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 221. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 222. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 223. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 224. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 225. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 226. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 227. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 228. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 229. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 230. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 231. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 236. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 237. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2027 (USD MILLION)
TABLE 238. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2027 (USD MILLION)
TABLE 239. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 240. GLOBAL NEUROVASCULAR DEVICES MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 241. GLOBAL NEUROVASCULAR DEVICES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 242. GLOBAL NEUROVASCULAR DEVICES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 243. GLOBAL NEUROVASCULAR DEVICES MARKET RANKING, BY KEY PLAYER, 2021
TABLE 244. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2021
TABLE 245. GLOBAL NEUROVASCULAR DEVICES MARKET MERGER & ACQUISITION
TABLE 246. GLOBAL NEUROVASCULAR DEVICES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 247. GLOBAL NEUROVASCULAR DEVICES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 248. GLOBAL NEUROVASCULAR DEVICES MARKET INVESTMENT & FUNDING
TABLE 249. GLOBAL NEUROVASCULAR DEVICES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 250. GLOBAL NEUROVASCULAR DEVICES MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Acandis GmbH
  • B. BRAUN MELSUNGEN AG
  • Cerus Endovascular Inc.
  • Evasc Medical Systems
  • Gynesonics, Inc.
  • Integer Holdings Corporation
  • Integra Lifesciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Oxford Endovascular Ltd
  • Penumbra, Inc.
  • phenox GmbH
  • Rapid Medical
  • Secant Group, LLC
  • Sensome
  • Stryker Corporation
  • Terumo Corporation

Methodology

Loading
LOADING...